Cibus, Inc.
NASDAQ:CBUSBiotechnology
Healthcare
$1.23 +3.10%
+$0.04 today
- Market cap
- $94.01M
- Beta
- 1.65
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.16
52W Low $1.09High $4.19
Volume 0.19M
Average 0.51M
Income Statement
Follow revenue through to earnings.
Revenue
$3.64M
FY 2025 · Annual
-14.6% YoYOperating Income
-$67.46M
FY 2025 · Annual
Net Income
-$127.08M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 25.99M | 157K | 1.82M | 4.26M | 3.64M |
| Cost of Revenue | 28.56M | 1.53M | 395K | 0 | 5.92M |
| Gross Profit | (2.57M) | (1.38M) | 1.42M | 4.26M | (2.28M) |
| Gross Margin | -9.9% | -877.1% | 78.3% | 100.0% | -62.8% |
| Research & Development | 11.34M | 11.55M | 42.37M | 50.43M | 44.2M |
| Selling, General & Admin | 15.38M | 9.44M | 28.91M | 30.8M | 26.91M |
| Operating Expenses | 26.76M | 20.99M | 320.31M | 262.66M | 65.18M |
| Depreciation & Amortization | 2.34M | 1.53M | 4.69M | 6.86M | 5.92M |
| EBITDA | (25.43M) | (15.21M) | (314.59M) | (241.64M) | (90.77M) |
| EBITDA Margin | -97.9% | -9687.9% | -17313.4% | -5669.5% | -2494.3% |
| Operating Income | (29.33M) | (22.37M) | (318.88M) | (258.4M) | (67.46M) |
| Operating Margin | -112.9% | -14248.4% | -17550.0% | -6062.8% | -1853.9% |
| Interest Income | 17K | 60K | 527K | 631K | 438K |
| Interest Expense | 1.43M | 87K | 18.89M | 34.19M | 35.48M |
| Other Income / Expenses | 133K | 5.48M | (18.76M) | (24.29M) | (64.71M) |
| Income Before Tax | (29.2M) | (16.89M) | (337.64M) | (282.68M) | (132.17M) |
| Pre-Tax Margin | -112.4% | -10758.6% | -18582.4% | -6632.7% | -3632.1% |
| Income Tax Expense | 0 | 0 | (4K) | 29K | 29K |
| Net Income | (29.2M) | (16.89M) | (267.63M) | (251.39M) | (127.09M) |
| Net Margin | -112.4% | -10758.6% | -14729.1% | -5898.4% | -3492.3% |
| EPS (Basic) | (0.05) | (0.03) | (25.95) | (10.83) | (2.78) |
| EPS (Diluted) | (0.05) | (0.03) | (25.95) | (10.83) | (2.78) |
| 578.47M | 578.47M | 10.31M | 23.22M | 457.57M | |
| 578.47M | 578.47M | 10.31M | 23.22M | 457.57M |
CBUS Earnings Waterfall · TTM
NASDAQ:CBUS · Revenue to Net Income
Key Ratios
EPS$-1.77
Gross Margin82.2%
Net Margin-2692.4%
P/E Ratio-5.7
P/S Ratio423.5
Analysis
$4.3M of revenue converted into -$101.4M of net income for the selected period. Gross margin is 82.2% and net margin is -2692.4%, showing how much revenue survives after costs and taxes. EPS is $-1.77, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 12, 2026 | |
| 8-K | Current report | Nov 12, 2026 |
How much revenue does CBUS generate?
Cibus, Inc. (CBUS) reported $3.64M of revenue in fiscal 2025.
Is CBUS profitable?
Cibus, Inc. (CBUS) reported -$127.08M of net income, with a net margin of -3492.3%.
Continue the stock analysis
Jump to another research area for this company.